Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Contin

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Journal of Parkinson'S Disease|November 14, 2022
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic MonitoringManuela Contin, Giovanna Lopane, Laura M B Belotti, et al.
Epilepsia|September 20, 2006
Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsyManuela Contin, Fiorenzo Albani, Giovanni Ambrosetto, et al.
Autonomic Neuroscience : Basic & Clinical|September 11, 2024
Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failureGiannicola Carrozzo, Mitchell G Miglis, Manuela Contin, et al.
Clinical Neuropharmacology|August 5, 2003
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitoneAgostino Baruzzi, Manuela Contin, Giovanni Barbara, et al.
Journal of Neurology|November 15, 2015
Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's diseaseGiovanna Calandra-Buonaura, Andrea Doria, Giovanna Lopane, et al.
Autonomic Neuroscience : Basic & Clinical|August 20, 2010
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophyPietro Guaraldi, Vincenzo Donadio, Sabina Capellari, et al.
Journal of Neuro-Oncology|July 10, 2008
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsyMarta Maschio, Fiorenzo Albani, Bruno Jandolo, et al.
Epilepsia|June 14, 2018
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsyManuela Contin, Francesca Bisulli, Margherita Santucci, et al.
Journal of Neurology|December 16, 2003
Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECTManuela Contin, Paolo Martinelli, Roberto Riva, et al.
Epilepsy & Behavior : E&B|August 29, 2020
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational studyManuela Contin, Federica Pondrelli, Lorenzo Muccioli, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Journal of Parkinson'S Disease|November 14, 2022
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic MonitoringManuela Contin, Giovanna Lopane, Laura M B Belotti, et al.
Epilepsia|September 20, 2006
Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsyManuela Contin, Fiorenzo Albani, Giovanni Ambrosetto, et al.
Autonomic Neuroscience : Basic & Clinical|September 11, 2024
Intrasubject reproducibility of supine norepinephrine plasma concentrations in patients with cardiovascular sympathetic failureGiannicola Carrozzo, Mitchell G Miglis, Manuela Contin, et al.
Clinical Neuropharmacology|August 5, 2003
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitoneAgostino Baruzzi, Manuela Contin, Giovanni Barbara, et al.
Journal of Neurology|November 15, 2015
Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's diseaseGiovanna Calandra-Buonaura, Andrea Doria, Giovanna Lopane, et al.
Autonomic Neuroscience : Basic & Clinical|August 20, 2010
Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophyPietro Guaraldi, Vincenzo Donadio, Sabina Capellari, et al.
Journal of Neuro-Oncology|July 10, 2008
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsyMarta Maschio, Fiorenzo Albani, Bruno Jandolo, et al.
Epilepsia|June 14, 2018
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsyManuela Contin, Francesca Bisulli, Margherita Santucci, et al.
Journal of Neurology|December 16, 2003
Assessing dopaminergic function in Parkinson's disease: levodopa kinetic-dynamic modeling and SPECTManuela Contin, Paolo Martinelli, Roberto Riva, et al.
Epilepsy & Behavior : E&B|August 29, 2020
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational studyManuela Contin, Federica Pondrelli, Lorenzo Muccioli, et al.
Pageof 7